UroTec’s MukoCell® made of autologous, in vitro cultured mucosa cells. Only a small biopsy needs to be taken from the patient.
Exit since August 2010.
UroTec GmbH gains strategic partner – Profitable exit for High-Tech Gründerfonds and Technologiegründerfonds Sachsen
APOGEPHA Arzneimittel GmbH has, as strategic investor, purchased a majority stake in UroTec GmbH, acquiring the shares from the previous shareholders. The rich-in-tradition, Saxony-based APOGEPHA pharmaceuticals company is an established producer of urology drugs and the ideal partner for the innovative UroTec…
Info & Contact
14. Feb 2008 – 25. Aug 2010